New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Study sheds light on one of the still poorly understood aspects of cancer

Study sheds light on one of the still poorly understood aspects of cancer

byPolytechnic University of MilanInnovative optical technologies for non-invasive microscopy allowed the research team to reveal the overproduction of lipid droplets, the mitochondrial network r
World medicine December 01,2023
Study sheds light on one of the still poorly understood aspects of cancer

Study sheds light on one of the still poorly understood aspects of cancer

byPolytechnic University of MilanInnovative optical technologies for non-invasive microscopy allowed the research team to reveal the overproduction of lipid droplets, the mitochondrial network r
World medicine December 01,2023
Brain cancer linked to nuclear pore alterations

Brain cancer linked to nuclear pore alterations

byKanazawa UniversityWe identify nuclear pore protein NUP107 as a significantly amplified and overexpressed gene with MDM2 which mediating p53 protein degradation in Glioblastoma. Loss of NUP107
World medicine December 01,2023
Brain cancer linked to nuclear pore alterations

Brain cancer linked to nuclear pore alterations

byKanazawa UniversityWe identify nuclear pore protein NUP107 as a significantly amplified and overexpressed gene with MDM2 which mediating p53 protein degradation in Glioblastoma. Loss of NUP107
World medicine December 01,2023
Good news, bad news on dental pain care seen in new study

Good news, bad news on dental pain care seen in new study

byUniversity of MichiganCredit: Unsplash/CC0 Public DomainAmericans who have a tooth pulled or another painful dental procedure in the United States today are far less likely to get opioid paink
World medicine December 01,2023
Good news, bad news on dental pain care seen in new study

Good news, bad news on dental pain care seen in new study

byUniversity of MichiganCredit: Unsplash/CC0 Public DomainAmericans who have a tooth pulled or another painful dental procedure in the United States today are far less likely to get opioid paink
World medicine December 01,2023
Special toothpaste may lower risk of allergic reactions for adults with peanut allergy

Special toothpaste may lower risk of allergic reactions for adults with peanut allergy

byAmerican College of Allergy, Asthma, and ImmunologyCredit: Unsplash/CC0 Public DomainOral immunotherapy for peanut allergy—introducing small amounts of peanut over a period of time to cause le
Pulmonology December 01,2023
Special toothpaste may lower risk of allergic reactions for adults with peanut allergy

Special toothpaste may lower risk of allergic reactions for adults with peanut allergy

byAmerican College of Allergy, Asthma, and ImmunologyCredit: Unsplash/CC0 Public DomainOral immunotherapy for peanut allergy—introducing small amounts of peanut over a period of time to cause le
Pulmonology December 01,2023
New treatment approach selectively targets cancer cell lysosomes and overcomes drug resistance

New treatment approach selectively targets cancer cell lysosomes and overcomes drug resistance

byUlsan National Institute of Science and TechnologyGraphical abstract. Credit:Journal of the American Chemical Society(2023). DOI: 10.1021/jacs.3c04467An anticancer treatment techno
World medicine December 01,2023
New treatment approach selectively targets cancer cell lysosomes and overcomes drug resistance

New treatment approach selectively targets cancer cell lysosomes and overcomes drug resistance

byUlsan National Institute of Science and TechnologyGraphical abstract. Credit:Journal of the American Chemical Society(2023). DOI: 10.1021/jacs.3c04467An anticancer treatment techno
World medicine December 01,2023
New insight into the crosstalk between cancer cells and their environment

New insight into the crosstalk between cancer cells and their environment

by Ananya Sen,University of Illinois at Urbana-ChampaignCAFs undergo significant gene expression changes when grown on substrates of increasing stiffness. Hierarchical clustered heatmaps showing
World medicine December 01,2023
New insight into the crosstalk between cancer cells and their environment

New insight into the crosstalk between cancer cells and their environment

by Ananya Sen,University of Illinois at Urbana-ChampaignCAFs undergo significant gene expression changes when grown on substrates of increasing stiffness. Hierarchical clustered heatmaps showing
World medicine December 01,2023
Digital risk assessment tool can ID risk for cancer susceptibility syndromes, according to study

Digital risk assessment tool can ID risk for cancer susceptibility syndromes, according to study

by Elana GotkineImplementation of a digital risk assessment tool can identify patients with high-risk cancer susceptibility syndromes, according to a study presented at the annual meeting of the Ameri
World medicine December 01,2023
Digital risk assessment tool can ID risk for cancer susceptibility syndromes, according to study

Digital risk assessment tool can ID risk for cancer susceptibility syndromes, according to study

by Elana GotkineImplementation of a digital risk assessment tool can identify patients with high-risk cancer susceptibility syndromes, according to a study presented at the annual meeting of the Ameri
World medicine December 01,2023
New way to kill breast cancer stem cells that have ancestral features and resist chemotherapy

New way to kill breast cancer stem cells that have ancestral features and resist chemotherapy

by Erika Rindsjö,Karolinska InstitutetCredit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI166666Researchers at Karolinska Institutet and Kanazawa University in Japan have
World medicine December 01,2023
New way to kill breast cancer stem cells that have ancestral features and resist chemotherapy

New way to kill breast cancer stem cells that have ancestral features and resist chemotherapy

by Erika Rindsjö,Karolinska InstitutetCredit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI166666Researchers at Karolinska Institutet and Kanazawa University in Japan have
World medicine December 01,2023
Telehealth's lasting impact on cancer care delivery

Telehealth's lasting impact on cancer care delivery

by Vincent Jacobbi,Mayo ClinicCredit: Pixabay/CC0 Public DomainA recent Mayo Clinicretrospective studypublished inJCO Oncology Practiceshows that cancer practices can int
World medicine December 01,2023
Telehealth's lasting impact on cancer care delivery

Telehealth's lasting impact on cancer care delivery

by Vincent Jacobbi,Mayo ClinicCredit: Pixabay/CC0 Public DomainA recent Mayo Clinicretrospective studypublished inJCO Oncology Practiceshows that cancer practices can int
World medicine December 01,2023
Key signaling protein identified as possible target for new therapies in hard-to-treat cancers

Key signaling protein identified as possible target for new therapies in hard-to-treat cancers

byAmerican Physiological SocietyCredit:Function(2023). DOI: 10.1093/function/zqad053The unique signaling protein known as TRPM7 can stimulate and interact with an important cellular
World medicine December 01,2023
Key signaling protein identified as possible target for new therapies in hard-to-treat cancers

Key signaling protein identified as possible target for new therapies in hard-to-treat cancers

byAmerican Physiological SocietyCredit:Function(2023). DOI: 10.1093/function/zqad053The unique signaling protein known as TRPM7 can stimulate and interact with an important cellular
World medicine December 01,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com